Genus plc Stock OTC Markets
Stocks
GENS.F
GB0002074580
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.06 USD | +0.29% |
|
-.--% | -11.24% |
| 06-09 | WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps | AN |
| 05-05 | Citi cuts Severn Trent and United Utilities | AN |
| Market Cap | 1.45B 1.95B 1.68B 1.55B 2.72B 185B 2.76B 18.32B 7.14B 90.18B 7.32B 7.16B 312B | P/E Ratio 2026 * |
13.1x | P/E Ratio 2027 * | 26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.56B 2.1B 1.81B 1.67B 2.93B 199B 2.97B 19.7B 7.68B 97B 7.87B 7.7B 336B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 2.29x |
| Free-Float |
99.2% | Yield 2026 * |
1.6% | Yield 2027 * | 1.65% |
Last Transcript: Genus plc
| 1 day | +0.29% | ||
| 1 month | -1.38% | ||
| 3 months | -16.60% | ||
| 6 months | -11.62% | ||
| Current year | -11.24% |
| 1 month | 31.06 | 31.06 | |
| Current year | 30.98 | 37.25 | |
| 1 year | 26.01 | 37.25 | |
| 3 years | 20.51 | 37.25 | |
| 5 years | 20.51 | 75 | |
| 10 years | 19.64 | 77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jorgen Kokke
CEO | Chief Executive Officer | 57 | 2023-06-30 |
Andy Russell
DFI | Director of Finance/CFO | - | 2025-07-31 |
Matt Culbertson
COO | Chief Operating Officer | - | 2010-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lysanne Gray
BRD | Director/Board Member | 62 | 2016-03-31 |
Lesley Knox
BRD | Director/Board Member | 73 | 2018-05-31 |
Iain Ferguson
CHM | Chairman | 69 | 2020-11-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.29% | -.--% | - | - | 1.94B | ||
| -0.35% | -0.22% | -15.03% | -12.88% | 42.96B | ||
| +3.11% | +3.11% | +274.29% | +507.94% | 31.73B | ||
| +0.22% | -1.08% | +14.03% | -14.37% | 30.22B | ||
| +1.62% | -2.08% | -4.36% | +24.05% | 28.94B | ||
| +4.09% | -1.98% | +11.99% | +17.37% | 23.87B | ||
| -1.63% | +2.88% | +53.73% | +114.36% | 13.57B | ||
| -0.40% | -1.48% | +7.48% | +7.12% | 12.96B | ||
| +1.14% | +3.62% | - | - | 13.39B | ||
| -0.74% | -1.62% | +105.71% | +76.01% | 12.2B | ||
| Average | +0.60% | -0.71% | +55.98% | +89.95% | 23.31B | |
| Weighted average by Cap. | +0.79% | -1.08% | +54.76% | +95.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 676M 907M 784M 722M 1.27B 86.25B 1.29B 8.53B 3.33B 41.98B 3.41B 3.33B 145B | 666M 894M 772M 711M 1.25B 84.97B 1.27B 8.4B 3.28B 41.36B 3.35B 3.28B 143B |
| Net income | 126M 169M 146M 134M 236M 16.03B 239M 1.59B 618M 7.8B 633M 620M 27.02B | 55.86M 74.98M 64.76M 59.67M 105M 7.13B 106M 705M 275M 3.47B 281M 275M 12.01B |
| Net Debt | 110M 147M 127M 117M 206M 14B 209M 1.38B 540M 6.81B 553M 541M 23.59B | 70.69M 94.89M 81.95M 75.52M 132M 9.02B 135M 892M 348M 4.39B 356M 349M 15.2B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- GNS Stock
- GENS.F Stock
Select your edition
All financial news and data tailored to specific country editions

















